• (+)-Bicuculline: Technical Use as a GABAA Receptor Antagonis

  2026-05-16

  (+)-Bicuculline enables precise inhibition of GABAA receptors to dissect inhibitory synaptic transmission and modulate NMDA receptor signaling in neuroscience assays. It should only be used in controlled research environments with rigorous attention to solubility, storage, and workflow protocols. This compound is not suitable for diagnostic or clinical applications.

• LY2228820: Precision p38 MAP Kinase Inhibitor for Cellular A

  2026-05-15

  LY2228820 empowers researchers to dissect p38 MAPK signaling with unprecedented selectivity, supporting robust anti-inflammatory and cancer research. This guide delivers actionable workflows, protocol optimizations, and troubleshooting strategies to maximize reproducibility and scientific insight.

• EV-Transferred ACLY Drives Immunosuppressive Macrophage Diff

  2026-05-15

  This study uncovers how hepatocellular carcinoma (HCC) cells use extracellular vesicles to deliver ATP-citrate lyase (ACLY) into monocytes, inducing their differentiation into tumor-associated macrophages (TAMs) with potent immunosuppressive properties. These insights inform targeted strategies to modulate the tumor microenvironment and enhance immunotherapy in HCC.

• SOAT1 Inhibition Restores Lipophagy in PHMG-Induced Lung Fib

  2026-05-14

  This study identifies sterol O-acyltransferase 1 (SOAT1) as a key mediator of pulmonary fibrosis following polyhexamethylene guanidine (PHMG) exposure, linking SOAT1 upregulation to disrupted cholesterol handling and foam cell formation in alveolar macrophages. Targeting SOAT1 with avasimibe restored lipophagy and mitigated fibrosis, suggesting a promising therapeutic direction for PHMG-induced and possibly other lipid-driven fibrotic lung diseases.

• Gamithromycin: PK/PD-Driven Workflows for Respiratory Pathog

  2026-05-14

  Gamithromycin (ML-1709460) unlocks precision targeting of veterinary respiratory pathogens with data-backed dosing strategies and advanced PK/PD modeling. This guide translates breakthrough findings into actionable workflows, tackling both in vitro and in vivo models with real-world troubleshooting and optimization tips.

• Repurposing Novobiocin: In Vitro Activity Against SFTSV

  2026-05-13

  This article examines the recent in vitro evaluation of Novobiocin, an aminocoumarin antibiotic, and other FDA-approved drugs for antiviral activity against severe fever with thrombocytopenia syndrome virus (SFTSV). The study identifies Novobiocin as a promising antiviral compound, offering new avenues for antiviral and antibacterial resistance research.

• 40-Hz Light Flicker Regulates Retinal Microglia for Amyloid

  2026-05-13

  This study demonstrates that 40-Hz light flicker enhances retinal amyloid-β clearance in aged mice by upregulating MHC-II+ microglia activity. The findings highlight a non-invasive strategy for promoting metabolic waste removal in age-related retinal disorders and establish a mechanistic link between flicker stimulation and immune modulation.

• RG108 (A1913): Practical Insights for Epigenetic Modulation

  2026-05-12

  This article provides an evidence-based exploration of RG108 (SKU A1913), a DNA methyltransferase inhibitor, guiding biomedical researchers through real-world experimental challenges in cell-based assays. It distills validated workflows, protocol considerations, and vendor reliability, emphasizing reproducibility and practical advantages of using RG108 from APExBIO.

• Simvastatin (Zocor): Applied Workflows in Lipid and Cancer R

  2026-05-12

  Simvastatin (Zocor) is a gold-standard tool for dissecting cholesterol biosynthesis and apoptosis induction in hepatic cancer models. This article delivers scenario-based protocols, advanced troubleshooting, and insights into leveraging high-content phenotypic profiling for robust, reproducible results using APExBIO’s research-grade compound.

• Filipin III (SKU B6034): Optimizing Cholesterol Detection Wo

  2026-05-11

  This article addresses real-world laboratory challenges in cholesterol detection and membrane analysis, focusing on how Filipin III (SKU B6034) delivers robust, reproducible performance for cell biology assays. Drawing on current literature and validated protocols, it guides researchers in leveraging Filipin III for sensitive, quantitative membrane cholesterol visualization while ensuring workflow reliability.

• Bestatin (Ubenimex): Data-Driven Solutions for Cell Assays

  2026-05-11

  This article explores how Bestatin (Ubenimex), particularly APExBIO SKU A2575, addresses critical pain points in cell viability, apoptosis, and multidrug resistance (MDR) research. Scenario-driven Q&A blocks provide practical, evidence-based guidance, ensuring reproducible and interpretable results in complex laboratory workflows.

• Neutrophil Extracellular Traps in CML: TKI Effects and Mecha

  2026-05-10

  This study demonstrates that neutrophil extracellular trap (NET) formation is elevated in chronic myeloid leukemia (CML) and that various tyrosine kinase inhibitors (TKIs) differentially modulate this process. The findings reveal a potential mechanistic link between TKI therapy, NETs, and vascular toxicity, providing new perspectives for CML pathogenesis and therapeutic evaluation.

• Baicalin and KEAP1-NRF2/HO-1 Pathway Modulation in Neuroplas

  2026-05-09

  Baicalin, a flavone glycoside from Scutellaria baicalensis, offers unique advantages for modulating neuroplasticity and cancer signaling, with reproducible outcomes in amblyopia and oncology models. APExBIO’s high-purity Baicalin enables advanced experimental designs by ensuring reliable pathway modulation and validated bioactivity.

• H-89 in Osteoblast Research: Precision Tools for cAMP Pathwa

  2026-05-08

  Explore how H-89, a potent cAMP-dependent protein kinase inhibitor, enables advanced dissection of cAMP signaling and metabolic rewiring in osteoblastogenesis. This article offers unique protocol insights and practical guidance for metabolic and bone research.

• Novobiocin: Aminocoumarin Antibiotic for Antimicrobial Workf

  2026-05-08

  Novobiocin enables potent antibacterial, antiparasitic, and antiviral workflows by uniquely targeting bacterial DNA gyrase and Hsp90. This guide translates its dual mechanism and protocol flexibility into reproducible, high-impact experimental strategies, with actionable troubleshooting tips for resistance and advanced phenotypic assays.

15135 records 1/1009 page Next 12345 下5页 Last page